Search & Filter
Date Range
Resource Type
HRS Endorsed
Audience
Topic
Manufacturer
Device Type
FDA Class
Safety Alerts
Safety Advisory Regarding A Subset of Boston Scientific EMBLEM™ S-ICDs
n August 21, 2019, Boston Scientific released an Urgent Medical Device Advisory regarding the performance of approximately 400 Model A209/A219 EMBLEM™ Subcutaneous Implantable Cardioverter Defibrillators…
August 21, 2019
Webinars
Webinar: 2018 ICD Coverage Policy
On February 15, 2018, the Centers for Medicare and Medicaid Services released an updated National Coverage Determination (NCD) for Implantable Cardiac Defibrillators (ICD).
June 18, 2019
Clinical Guidelines
2003 NASPE Policy Statement on Catheter Ablation
This Policy Statement provides updates about the rationale and indications for catheter ablative procedures and recommendations regarding electrophysiology laboratory personnel and facilities. NASPE stands for…
June 18, 2019
Comment Letter
Place of Heath Care Policy in EP Fellowship
Fred M. Kusumoto, MD, FHRS and Pamela K. Mason, MD, FHRS discuss how to incorporate healthcare policy into the training of young physicians.
May 21, 2019
Video
MACRA’S Impact on EPs
Fred M. Kusumoto, MD, FHRS and Pamela K. Mason, MD, FHRS discuss how MACRA affect electrophysiologists.
May 21, 2019
Video
Practicing Electrophysiology in the New Healthcare System
Fred M. Kusumoto, MD, FHRS and Pamela K. Mason, MD, FHRS discuss how MACRA will affect electrophysiology care in the future.
May 21, 2019
Clinical Guidelines
2019 HRS/EHRA/APHRS/LAHRS Focused Update to 2015 Expert Consensus Statement on Optimal Implantable Cardioverter-Defibrillator Programming and Testing
Developed in partnership with and endorsed by the European Heart Rhythm Association, the Asia Pacific Heart Rhythm Society, and the Latin American Heart Rhythm Society,…
May 15, 2019
Clinical Guidelines
2019 HRS/EHRA/APHRS/LAHRS Expert Consensus Statement on Catheter Ablation of Ventricular Arrhythmias
The consensus statement, accompanied by a systematic review and meta-analysis and an Executive Summary, serves as a resource guide and comprehensive review of the field for clinicians…
May 10, 2019
Clinical Guidelines
2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy
The expert consensus statement defines the broader condition of arrhythmogenic cardiomyopathy (ACM) that incorporates a spectrum of genetic, systematic, infectious, and inflammatory disorders. The designation…
May 9, 2019
Comment Letter
HRS Comments – AHRQ Report on the Use of CRT (July 2019)
July 24, 2019